 We, the researchers at Centre National de Greffe de Moelle Osseuse, have shown in a randomised study in press, that a low dose of unfractionated heparin 100 IUkgdaily was safe and effective to prevent catheter-related bloodstream infection in patients with haemato-oncological disease. 